Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novel tri-action somatostatin-dopamine agonists studied for control of GH secretion

July 15, 2005

AZD-0530 inhibits osteoclast-mediated bone resorption in healthy volunteers

July 15, 2005

Lithium shows promise as anabolic bone therapy

July 15, 2005

Drug discovery targets for diabetes

July 14, 2005

Second phase II trial for Hematide in chronic kidney disease patients

July 14, 2005

New data on the potential of ferumoxytol as iron replacement therapy

July 14, 2005

Etanercept reported to reduce bone resorption in psoriatic arthritis

July 14, 2005

Good PK and safety profile reported for AMG-162 in healthy men

July 14, 2005

Prous Science webcasts more than 100 hours of ADA 65th Scientific Session

July 13, 2005

AstraZeneca and Avanir establish reverse cholesterol transport collaboration

July 13, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...